|
Cancer Diagnostics (since 2002)
Citations 171-180 of 190 total displayed.
|
Past content
(since Aug 2002):
|
- Articles
Detection of Human Kallikrein 4 in Healthy and Cancerous Prostatic Tissues by Immunofluorometry and Immunohistochemistry
- Christina V. Obiezu, Antoninus Soosaipillai, Klaus Jung, Carsten Stephan, Andreas Scorilas, David H. C. Howarth, and Eleftherios P. Diamandis
Clin. Chem. 2002; 48: 1232-1240.
[Abstract]
[Full text]
[PDF]
- Articles
Human Kallikrein Gene 5 (KLK5) Expression by Quantitative PCR: An Independent Indicator of Poor Prognosis in Breast Cancer
- George M. Yousef, Andreas Scorilas, Lianna G. Kyriakopoulou, Laura Rendl, Maria Diamandis, Riccardo Ponzone, Nicoletta Biglia, Maurizia Giai, Riccardo Roagna, Piero Sismondi, and Eleftherios P. Diamandis
Clin. Chem. 2002; 48: 1241-1250.
[Abstract]
[Full text]
[PDF]
- Articles
The Proportion of Prostate-specific Antigen (PSA) Complexed to  1-Antichymotrypsin Improves the Discrimination between Prostate Cancer and Benign Prostatic Hyperplasia in Men with a Total PSA of 10 to 30 µg/L
- Manuel Martínez, Francisco España, Montserrat Royo, José M. Alapont, Silvia Navarro, Amparo Estellés, Justo Aznar, César D. Vera, and Juan F. Jiménez-Cruz
Clin. Chem. 2002; 48: 1251-1256.
[Abstract]
[Full text]
[PDF]
- Articles
Sensitive and Specific Enzymatic Assay for the Determination of Precursor Forms of Prostate-specific Antigen after an Activation Step
- Pauliina Niemelä, Janita Lövgren, Matti Karp, Hans Lilja, and Kim Pettersson
Clin. Chem. 2002; 48: 1257-1264.
[Abstract]
[Full text]
[PDF]
- Articles
Simultaneous Quantification of Prostate-specific Antigen and Human Glandular Kallikrein 2 mRNA in Blood Samples from Patients with Prostate Cancer and Benign Disease
- Alice Ylikoski, Kim Pettersson, Jussi Nurmi, Kerttu Irjala, Matti Karp, Hans Lilja, Timo Lövgren, and Martti Nurmi
Clin. Chem. 2002; 48: 1265-1271.
[Abstract]
[Full text]
[PDF]
- Articles
Measurement of Prostate-specific Antigen by Use of a Novel Blood Collection and Analytical System
- Barbara R. Grzeda, Tuan Le Bui, Cheryl N. Warner, Tracy L. Pirucki, Lisa M. Dewey, Milan Babich, and Jack A. Maggiore
Clin. Chem. 2002; 48: 1272-1278.
[Abstract]
[Full text]
[PDF]
- Articles
Multicenter Evaluation of an Artificial Neural Network to Increase the Prostate Cancer Detection Rate and Reduce Unnecessary Biopsies
- Carsten Stephan, Henning Cammann, Axel Semjonow, Eleftherios P. Diamandis, Leon F.A. Wymenga, Michael Lein, Pranav Sinha, Stefan A. Loening, and Klaus Jung
Clin. Chem. 2002; 48: 1279-1287.
[Abstract]
[Full text]
[PDF]
- Articles
Quantitative Real-Time Reverse Transcription-PCR Assay for Urokinase Plasminogen Activator, Plasminogen Activator Inhibitor Type 1, and Tissue Metalloproteinase Inhibitor Type 1 Gene Expressions in Primary Breast Cancer
- Remedios Castelló, Amparo Estellés, Carlos Vázquez, Cristina Falcó, Francisco España, Sergio M. Almenar, Carlos Fuster, and Justo Aznar
Clin. Chem. 2002; 48: 1288-1295.
[Abstract]
[Full text]
[PDF]
- Articles
Proteomics and Bioinformatics Approaches for Identification of Serum Biomarkers to Detect Breast Cancer
- Jinong Li, Zhen Zhang, Jason Rosenzweig, Young Y. Wang, and Daniel W. Chan
Clin. Chem. 2002; 48: 1296-1304.
[Abstract]
[Full text]
[PDF]
- Articles
Measurement of the Noncomplexed Free Fraction of Tissue Inhibitor of Metalloproteinases 1 in Plasma by Immunoassay
- Mads N. Holten-Andersen, Ib Jarle Christensen, Hans Jørgen Nielsen, Hans Lilja, Gillian Murphy, Vibeke Jensen, Nils Brünner, and Timo Piironen
Clin. Chem. 2002; 48: 1305-1313.
[Abstract]
[Full text]
[PDF]
|
|
